Literature DB >> 10355398

Management of exsanguinating hemoptysis during cardiopulmonary bypass.

W R Smythe1, R C Gorman, W M DeCampli, T L Spray, L R Kaiser, M A Acker.   

Abstract

BACKGROUND: Large-volume hemoptysis during cardiopulmonary bypass is an infrequent, but life-threatening event. Rapid airway clearance and control are the primary prerequisites for successful management.
METHODS: The cases of 3 patients with different sources of exsanguinating hemoptysis during cardiopulmonary bypass managed initially with rigid bronchoscopy were reviewed.
RESULTS: In all patients, airway control was rapidly established and weaning from cardiopulmonary bypass CPB was accomplished. Two patients survived the operative procedure. The other patient died in the operating room of unremitting bilateral pulmonary hemorrhage.
CONCLUSIONS: Major hemoptysis during cardiopulmonary bypass is best dealt with initially by rapid airway control and cessation of bypass in an expeditious manner. An algorithm for suggested management is provided. The rigid bronchoscope is the optimal tool for initial management and it should always be available. Definitive treatment is determined by the cause and the persistence of hemorrhage once these maneuvers have been performed.

Entities:  

Mesh:

Year:  1999        PMID: 10355398     DOI: 10.1016/s0003-4975(99)00214-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Retrograde pulmonary perfusion improves results in pulmonary embolectomy for massive pulmonary embolism.

Authors:  Salvatore Spagnolo; Maria Antonia Grasso; Ugo Filippo Tesler
Journal:  Tex Heart Inst J       Date:  2006

2.  Idiopathic bronchial hemorrhage: a rare but catastrophic complication in cardiac surgery.

Authors:  Takeshi Uzuka; Masanori Nakamura; Tomohiro Nakajima; Shinichi Kusudoh; Hiroaki Usubuchi; Akihiko Tanaka; Noriyasu Watanabe
Journal:  J Cardiothorac Surg       Date:  2016-05-05       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.